BIOSPECIFICS TECHNOLOGIES CORP 4
4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed May 27, 2015
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2015-04-06$39.25/sh−2,000$78,500→ 515,556 total(indirect: Footnote) - Sale
Common Stock
2015-03-20$39.15/sh−4,010$156,992→ 525,417 total(indirect: Footnote) - Sale
Common Stock
2015-04-08$39.69/sh−2,500$99,225→ 508,656 total(indirect: Footnote) - Sale
Common Stock
2014-08-14$28.85/sh−2,785$80,347→ 531,945 total(indirect: Footnote) - Sale
Common Stock
2015-03-31$39.15/sh−2,000$78,300→ 518,656 total(indirect: Footnote) - Sale
Common Stock
2015-01-05$27.05/sh−2,518$68,112→ 529,427 total(indirect: Footnote) - Sale
Common Stock
2015-03-30$38.90/sh−4,761$185,203→ 520,656 total(indirect: Footnote) - Sale
Common Stock
2015-04-01$39.00/sh−1,100$42,900→ 517,556 total(indirect: Footnote) - Sale
Common Stock
2015-04-07$39.70/sh−4,400$174,680→ 511,156 total(indirect: Footnote)
Footnotes (1)
- [F1]The above shares were sold by the Jeanette Vogel Family Trust for whom, Jeffrey K. Vogel is one of the Trustees.